Cholinesterase Inhibitors as Therapy in Alzheimer’s Disease: Benefit to Risk Considerations in Clinical Application

Becker, R. E., Moriearty, P., Unni, L., & Vicari, S. (1997). Cholinesterase Inhibitors as Therapy in Alzheimer’s Disease: Benefit to Risk Considerations in Clinical Application. In Alzheimer Disease (pp. 257–266). Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4116-4_38